Virtus LifeSci Buy or Sell Recommendation

Macroaxis provides Virtus LifeSci Biotech Clinical Trls ETF buy hold or sell recommendation only in the context of selected investment horizon and investor attitude towards risk assumed by holding Virtus LifeSci positions. The advice algorithm takes into account all of Virtus LifeSci Biotech Clinical Trls ETF available fundamental, technical, and predictive indicators you will find on this site. The advice is provided from Virtus LifeSci buy-and-hold prospective. Check also Virtus LifeSci Analyst Recommendation to compare Macroaxis Buy or Sell Recommendation with current analyst consensus

Time Horizon

Risk Tolerance

Execute Advice
Virtus LifeSci Biotech Clinical Trls ETF -- USA Etf  

USD 35.06  0.87  2.54%

Considering 30-days investment horizon, and your above average risk tolerance our recommendation regarding Virtus LifeSci Biotech Clinical Trls ETF is 'Strong Buy'.
For the selected time horizon Virtus LifeSci Biotech Clinical Trls ETF has a risk adjusted performance of 0.1837, jensen alpha of 0.2156, total risk alpha of 0.2499, sortino ratio of 0.1811 and treynor ratio of 0.6083
Virtus LifeSci Biotech recommendation module can be used to check and cross-verify current buy or sell recommendation provided by analysts inspecting the organization potential to grow using all of fundamental, technical, data market data available at the time. Please use Virtus LifeSci Biotech Total Asset, and the relationship between Price to Sales and Three Year Return to make buy, hold, or sell decision on Virtus LifeSci.

Returns Distribution Density

Mean Return0.21Value At Risk2.16
Potential Upside1.71Standard Deviation1.36
 Return Density 

Virtus LifeSci Greeks

Alpha over DOW
Beta against DOW=0.33
Overall volatility
Information ratio =0.18

Virtus LifeSci Volatility Alert

Virtus LifeSci Biotech Clinical Trls ETF has relatively low volatility with skewness of 0.12 and kurtosis of -0.15. However, we advise all investors to independently investigate Virtus LifeSci Biotech Clinical Trls ETF to ensure market all accessible information is consistent with the expectations about its upside potential and future risk-adjusted return.
 Better Than Average     
 Worse Than Average Compare Virtus LifeSci to competition
FundamentalsVirtus LifeSciPeer Average
Price to Earning39.87 times8.24 times
Price to Book1.75 times0.97 times
Price to Sales1.99 times0.72 times
One Year Return65.59 % (1.25) %
Three Year Return4.67 % 2.26 %
Net Asset54.88 M888.73 M
Equity Positions Weight100.00 % 49.22 %
Strong Buy


Hype Condition

Current Valuation

Odds of Distress

Economic Sensitivity

Analyst Consensus

Currently Unavailable

Piotroski F Score

Financial Leverage

Risk Adjusted Performance0.1837
Market Risk Adjusted Performance0.6183
Mean Deviation1.08
Semi Deviation1.04
Downside Deviation1.34
Coefficient Of Variation643.33
Standard Deviation1.36
Information Ratio0.1783
Jensen Alpha0.2156
Total Risk Alpha0.2499
Sortino Ratio0.1811
Treynor Ratio0.6083
Maximum Drawdown5.43
Value At Risk2.16
Potential Upside1.71
Downside Variance1.8
Semi Variance1.08
Expected Short fall1.18